What Inner Breast Asymmetry on Mammogram Means
Inner breast asymmetry on mammography represents an area of increased density in one breast compared to the corresponding area in the opposite breast, which most commonly reflects benign summation artifact from overlapping normal breast tissue, but requires immediate diagnostic workup because it can indicate underlying malignancy including ductal carcinoma in situ (DCIS) or invasive cancer. 1, 2
Clinical Significance and Cancer Risk
The meaning of inner breast asymmetry depends critically on whether it is new or increasing (termed "developing asymmetry") versus stable:
- Developing asymmetry carries a positive predictive value of 12.8% for cancer at screening mammography and 42.9% when biopsy is ultimately recommended, making it sufficiently suspicious to justify recall and tissue sampling 1, 3
- Stable asymmetry without associated findings (no mass, microcalcifications, or architectural distortion) and no palpable abnormality represents normal variation in the vast majority of cases 4
- Low and intermediate-grade DCIS can present as asymmetry without calcifications, so absence of calcifications does not exclude malignancy 5, 1
Immediate Diagnostic Algorithm
The American College of Radiology mandates the following stepwise evaluation: 1, 2
Diagnostic mammography with spot compression views to determine if the asymmetry persists or disappears (indicating summation artifact from overlapping normal tissue) 1, 2
Magnification views if any associated microcalcifications are present, as these are particularly helpful for characterizing calcifications 1
Targeted ultrasound performed concurrently to identify potentially benign causes and provide a biopsy target if indicated 1, 2
BI-RADS classification based on cumulative findings from all imaging modalities 1
Management Based on BI-RADS Assessment
For BI-RADS 1-3 (Negative, Benign, or Probably Benign): 1
- Clinical re-examination in 3-6 months
- Follow-up imaging with diagnostic mammogram and/or ultrasound every 6-12 months for 1-2 years to assess stability
- Return to routine screening if stable
For BI-RADS 4-5 (Suspicious or Highly Suggestive of Malignancy): 1, 2
- Proceed directly to image-guided core needle biopsy (preferred over excisional biopsy)
- Biopsy is mandatory if the asymmetry is associated with suspicious microcalcifications, architectural distortion, palpable abnormality, or new/increasing size compared to prior studies 1
Critical Pitfalls to Avoid
- Never dismiss asymmetry without additional views, as summation artifact must be excluded with spot compression before providing reassurance 2
- Do not rely on mammography alone, as ultrasound identifies additional lesions not visible on mammography in 63-69% of symptomatic cases 2
- Normal ultrasound does not exclude malignancy: 23.8% of cancers presenting as developing asymmetry had no sonographic correlate 1, 3
- Ensure appropriate follow-up even with negative additional imaging (BI-RADS 3), as short-interval follow-up for 1-2 years is necessary to confirm stability 2
Special Considerations
- Mammography alone has relatively low sensitivity (15-68%) for detecting malignancy, with specificity ranging 38-98%, emphasizing the importance of multimodal evaluation 2
- Digital breast tomosynthesis (DBT) can replace traditional spot compression views in many diagnostic situations, providing equivalent or superior diagnostic accuracy while potentially reducing radiation exposure 1
- In premenopausal women, developing asymmetry may represent pseudoangiomatous stromal hyperplasia, a benign condition that can increase over time, but this remains a diagnosis of exclusion requiring tissue confirmation 6